LEADER 00957nam 22003493 450 001 9910131995103321 005 20200316114246.0 010 $a88-87543-98-4 035 $a(CKB)3400000000018928 035 $a(ItFiC)it 02414842 035 $a(EXLCZ)993400000000018928 100 $a20101102d2005 uy 0 101 0 $aita 200 00$aNuovi frammenti d'Europa $eriscritture, traduzioni, riviste del Novecento /$fa cura di Carla Gubert 210 $aPesaro $cMetauro$d2005 215 $a207 p. ;$d22 cm 225 0$aArchivio ;$v8 300 $aCollected essays. 320 $aIncludes bibliographical references. 517 $aNuovi frammenti d'Europa 676 $a809 676 $a851 676 $a940 676 $a418 676 $a805 701 $aGubert$b Carla$01021964 801 0$bItFiC 801 1$bItFiC 906 $aBOOK 912 $a9910131995103321 996 $aNuovi frammenti d'Europa$92429311 997 $aUNINA LEADER 05500nam 2200673 450 001 9910140462003321 005 20230807210355.0 010 $a1-118-64058-6 010 $a1-118-64056-X 035 $a(CKB)2670000000613905 035 $a(EBL)2036180 035 $a(SSID)ssj0001498010 035 $a(PQKBManifestationID)11874268 035 $a(PQKBTitleCode)TC0001498010 035 $a(PQKBWorkID)11501893 035 $a(PQKB)10689740 035 $a(MiAaPQ)EBC3059102 035 $a(MiAaPQ)EBC2036180 035 $a(DLC) 2015005256 035 $a(Au-PeEL)EBL3059102 035 $a(CaPaEBR)ebr11050662 035 $a(CaONFJC)MIL778968 035 $a(OCoLC)922954958 035 $a(EXLCZ)992670000000613905 100 $a20150202d2015 uy| 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aOveractive bladder $epractical management /$fedited by Jacques Corcos, Scott MacDiarmid, John Heesakkers 210 1$aChichester, West Sussex, United Kingdom ;$aHoboken, New Jersey :$cJohn Wiley & Sons,$d2015. 215 $a1 online resource (272 p.) 300 $aDescription based upon print version of record. 311 $a1-118-64059-4 311 $a1-118-64061-6 320 $aIncludes bibliographical references and index. 327 $aTitle Page; Copyright Page; Contents; Contributors; Foreword; Foreword: The impact of Overactive Bladder on Urogynecology; Foreword; Preface; Section 1 Introduction; Chapter 1 Overactive bladder: terminology and problem spectrum; References; Chapter 2 Pathophysiology; Introduction; The innervation of the bladder; The genesis of the NDO: three hypothesis; The link to the clinic; The neurological pathologies responsible for the development of the neurogenic bladder; Histological changes; Conclusions; References; Section 2 Evaluation; Chapter 3 Timing for evaluation; Conclusion; References 327 $aChapter 4 Clinical evaluation Introduction; History; Neurological history; General gynecological history; Obstetric history; Other relevant past medical and surgical history; Drug history; Examination; Questionnaires and quality of life; Summary; References; Chapter 5 Urodynamic evaluation of the overactive bladder; Introduction; OAB and urodynamics; Filling cystometry and OAB; Cystometrogram; Does OAB equal urodynamic DO? A clinical correlation; Pressure-flow studies and OAB; Summary; References; Chapter 6 Other testing; Bladder/detrusor wall thickness; Biomarkers; Near infrared spectroscopy 327 $aBladder wall strain imaging Autonomic nervous system; Functional brain imaging; Conclusions; References; Section 3 First Line Management; Chapter 7 Changes in lifestyle; Introduction; Lifestyle modifications; Obesity; Smoking; Extremes of daily fluid intake; Dietary bladder irritants; Constipation and straining at stool; Summary; References; Patient Guide 1 Lifestyle changes that can improve bladder symptoms; Maintain a healthy weight; Stop smoking; Moderate liquid and beverage intake; Monitor your diet; Maintain bowel regularity; Chapter 8 Physical therapy; Physical therapy 327 $aScheduled voiding/bladder training Pelvic floor muscle training; Electrical stimulation; References; Section 4 Second Line Management; Chapter 9 Oral medication for overactive bladder; Introduction; Antimuscarinics; Beta 3 (?3) adrenergic receptor (AR) agonists; Antidepressants; References; Chapter 10 Patches and gels; Rationale for TD OXY delivery; Drug pharmacology; Conclusion/expert opinion; References; Chapter 11 Promising experimental drugs and drug targets; Introduction; P2X3-receptors and P2X3 receptor antagonists; The cannabinoid system; TRP channels; References 327 $aChapter 12 The role of co-medication in the treatment of OAB Introduction; Antimuscarinics and ?-adrenoreceptor antagonists; Phosphodiesterase-5 inhibitors and ?-adrenoreceptor antagonists; Other combination regimens; Future directions; References; Chapter 13 Other non-surgical approaches for the treatment of overactive bladder; Introduction; Bladder training; Acupuncture; Naturopathic and herbal remedies; Magnetic stimulation; Containment products; Future: tissue engineering and gene therapy; Conclusion; Abbreviations; Financial and competing interests disclosure; References 327 $aSection 5 Third Line Management 330 $aOveractive Bladder: Practical Management provides urologists, gynecologists and other health practitioners with a comprehensive clinical guide to this very common problem, resulting in a perfect resource to consult time and time again. Beginning with an introductory section covering the definition and pathophysiolgy of OAB, it then moves on to cover evaluation, first-line management, second-line management and finally surgery. Well-illustrated throughout, each chapter begins with a key points box outlining the most important take-home messages. Also included are clear management algorithms 606 $aUrinary incontinence$xTreatment 606 $aBladder$xDiseases$xTreatment 615 0$aUrinary incontinence$xTreatment. 615 0$aBladder$xDiseases$xTreatment. 676 $a616.6/2 702 $aCorcos$b Jacques 702 $aMacDiarmid$b Scott A. 702 $aHeesakkers$b John 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910140462003321 996 $aOveractive bladder$91984648 997 $aUNINA